Kaloba Direkt (Dry Extract From Pelargonium Sidoides Root (6,25-11,11:1), Extraction Solvent: Ethanol 11% (W/W))

The extract contains polyphenols that exhibit antimicrobial, anti‑inflammatory and immunomodulatory properties. It is believed to stimulate macrophage activity, increase interferon production and modulate cytokine release, thereby enhancing the innate immune response to respiratory pathogens.

The appropriate dose of Kaloba Direkt is determined by the prescribing healthcare professional based on the patient’s age, condition and overall health. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for Pelargonium sidoides dry extract in pregnancy and lactation are limited. It should only be used during pregnancy or while breastfeeding if the potential benefit justifies the possible risk, and after consultation with a qualified healthcare provider.

To order Kaloba Direkt, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Kaloba Direkt belongs to the herbal medicine class, whereas the main alternatives for acute bronchitis are often antibiotics or symptomatic cough suppressants. Unlike antibiotics, the extract does not target bacterial pathogens directly but supports the immune response, offering a non‑antibiotic option for mild to moderate respiratory infections.

Kaloba Direkt should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency throughout its shelf life.

Kaloba Direkt is taken orally. The dosage form is typically a tablet, capsule or liquid preparation that is swallowed with water as directed by the prescriber. It is not intended for parenteral or topical use.

The most serious risks include rare but severe allergic reactions such as anaphylaxis, significant skin eruptions, and possible liver enzyme elevations. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, persistent rash, or jaundice.

Kaloba Direkt should be avoided by individuals with known hypersensitivity to Pelargonium sidoides or any component of the formulation. It is also contraindicated in patients with severe liver disease, uncontrolled asthma, or those taking medications that may interact severely without medical supervision.